Shopping Cart
Remove All
Your shopping cart is currently empty
XMD-12 is a selective pan-Aurora Kinase inhibitor, with an IC50 of 5.6/18.4/24.6 nM for Aurora A/B/C, with anti-tumor activity, and can promote the apoptosis of cancer cells induced by paclitaxel.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $293 | - | In Stock | |
| 5 mg | $722 | - | In Stock | |
| 10 mg | $987 | - | In Stock | |
| 25 mg | $1,520 | - | In Stock | |
| 50 mg | $1,980 | - | In Stock | |
| 100 mg | $2,500 | - | In Stock |
| Description | XMD-12 is a selective pan-Aurora Kinase inhibitor, with an IC50 of 5.6/18.4/24.6 nM for Aurora A/B/C, with anti-tumor activity, and can promote the apoptosis of cancer cells induced by paclitaxel. |
| Targets&IC50 | Aurora B:18.4 nM, Aurora A:5.6 nM, Aurora C:24.6 nM |
| Synonyms | XMD12, XMD 12 |
| Molecular Weight | 430.5 |
| Formula | C24H26N6O2 |
| Cas No. | 1234481-08-3 |
| Smiles | O=C1C=2C=CC=CC2N(C3=NC(=NC=C3N1C)NC4=CC=C(C=C4)N5CCC(O)CC5)C |
| Color | Yellow |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (185.83 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.